Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
IN |
|
Aditya Birla Capital Ltd
NSE:ABCAPITAL
|
IN |
|
Talanx AG
XETRA:TLX
|
DE |
Apollo Hospitals Enterprise Ltd
In the bustling corridors of Indian healthcare, Apollo Hospitals Enterprise Ltd. stands as a beacon of innovation and quality healthcare service. Founded in 1983 by Dr. Prathap C. Reddy, Apollo was one of the pioneers in bringing private healthcare to India, setting a new benchmark for service standards in the industry. It positioned itself as a leader by establishing a network of nearly 70 hospitals across the nation, offering a comprehensive range of services from routine and preventive care to complex surgeries and cancer treatments. This extensive network allows Apollo to capitalize on economies of scale, optimize resource allocation, and deliver cost-effective healthcare solutions. Its sophisticated hospitals often boast the latest medical technologies and employ highly trained healthcare professionals, ensuring patients receive top-notch care.
Beyond its core hospital operations, Apollo has diversified its revenue streams through pharmacies, primary care and diagnostic clinics, telemedicine, and healthcare consulting. The pharmacy business, with a massive network of stores, not only serves walk-in customers but also acts as a critical logistical backbone for the hospitals, providing an integrated supply of medicines and healthcare products. This vertical integration ensures availability and enhances the patient experience while contributing significantly to the company’s bottom line. By embracing a digital-first approach, Apollo's telemedicine and health tech investments are bridging gaps in healthcare accessibility, particularly for rural or underserved populations. Altogether, Apollo Hospitals Enterprise Ltd. has created a robust model that not only addresses the healthcare needs of millions but also consistently generates substantial revenue growth.
In the bustling corridors of Indian healthcare, Apollo Hospitals Enterprise Ltd. stands as a beacon of innovation and quality healthcare service. Founded in 1983 by Dr. Prathap C. Reddy, Apollo was one of the pioneers in bringing private healthcare to India, setting a new benchmark for service standards in the industry. It positioned itself as a leader by establishing a network of nearly 70 hospitals across the nation, offering a comprehensive range of services from routine and preventive care to complex surgeries and cancer treatments. This extensive network allows Apollo to capitalize on economies of scale, optimize resource allocation, and deliver cost-effective healthcare solutions. Its sophisticated hospitals often boast the latest medical technologies and employ highly trained healthcare professionals, ensuring patients receive top-notch care.
Beyond its core hospital operations, Apollo has diversified its revenue streams through pharmacies, primary care and diagnostic clinics, telemedicine, and healthcare consulting. The pharmacy business, with a massive network of stores, not only serves walk-in customers but also acts as a critical logistical backbone for the hospitals, providing an integrated supply of medicines and healthcare products. This vertical integration ensures availability and enhances the patient experience while contributing significantly to the company’s bottom line. By embracing a digital-first approach, Apollo's telemedicine and health tech investments are bridging gaps in healthcare accessibility, particularly for rural or underserved populations. Altogether, Apollo Hospitals Enterprise Ltd. has created a robust model that not only addresses the healthcare needs of millions but also consistently generates substantial revenue growth.
Strong Revenue Growth: Apollo Hospitals reported consolidated revenue growth of 17% year-on-year in Q3 FY '26 to INR 6,477 crores, with double-digit growth across all business verticals.
Margin Expansion: Consolidated EBITDA rose 27% year-on-year to INR 965 crores, and PAT increased 35% to INR 502 crores, with hospital margins at 24.8%.
Digital & Pharmacy Trends: Apollo HealthCo's revenues grew 20% year-on-year, while its digital business reduced cash losses to INR 29 crores, approaching breakeven (now expected in Q1 FY '27, delayed by a quarter due to insurance revenue recognition changes).
Capacity Expansion: The company is adding about 1,500 new beds through four new hospitals, with roughly half to be operationalized in the upcoming fiscal year and 40%–50% of these beds coming online by Q1.
Growth Drivers: Growth was well-balanced: 5% from volume, 4% from case mix, and 5% from pricing, with high-acuity specialties (cardiac, oncology, etc.) driving a 16% revenue increase.
Guidance & Outlook: Management reaffirmed a target run rate of INR 25,000 crores in combined revenues with 7% EBITDA margin, and expects to maintain current hospital margins while offsetting new hospital startup losses.
